ליטורבה 80 Ισραήλ - Εβραϊκά - Ministry of Health

ליטורבה 80

dexcel pharma technologies ltd - atorvastatin as calcium - טבליה - atorvastatin as calcium 80 mg - atorvastatin - atorvastatin - litorva is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. litorva is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) :atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190

ליטורבה 80 Ισραήλ - Εβραϊκά - Ministry of Health

ליטורבה 80

dexcel pharma technologies ltd - atorvastatin as calcium - טבליה - atorvastatin as calcium 80 mg - atorvastatin - atorvastatin - litorva is indicated as an adjunct to diet for reduction of elevated total cholesterol ldl- cholesterol apolipoprotein b and triglycerides and to increase hdl cholesterol in patients with primary hypercholesterolaemia including familial hypercholesterolaemia (heterozygous variant) or combined (mixed) hyperlipidaemia (corresponding to types iia and iib of the fredrickson classification) when response to diet and other nonpharmacological measures is inadequate. litorva is also indicated to reduce total-c and ldl -c in patients with homozygous familial hypercholesterolemia as an adjunct to other lipid-lowering treatment (e.g. ldl apheresis) or if such treatments are unavailable. pediatric patients (10-17 years of age) :atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190

בולגרי אקווה מרין - אפטר שייב תחליב Ισραήλ - Εβραϊκά - Ministry of Health

בולגרי אקווה מרין - אפטר שייב תחליב

שמעון שסטוביץ בעמ - לחות ובישום הפנים לאחר גילוח

בולגרי אקווה מרין - אפטר שייב LOTION Ισραήλ - Εβραϊκά - Ministry of Health

בולגרי אקווה מרין - אפטר שייב lotion

שמעון שסטוביץ בעמ - בישום הפנים לאחר גילוח

לנקום נוטריקס רויאל קרם ידיים Ισραήλ - Εβραϊκά - Ministry of Health

לנקום נוטריקס רויאל קרם ידיים

אינטרביוטי קוסמטיקס ישראל בעמ - קרם ידיים